Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	574.96	284.12	422.64	352.98	147.46	121.79
Trading Asset Securities	-	-	-	-	200.31	341.06
Cash & Short-Term Investments	574.96	284.12	422.64	352.98	347.78	462.85
Cash Growth	16.64%	-32.77%	19.73%	1.50%	-24.86%	644.14%
Accounts Receivable	351.15	416.78	374.28	318.43	326.39	222.79
Other Receivables	14.23	11.89	16.48	10.47	13.56	12.03
Receivables	365.38	428.67	390.76	328.89	339.95	234.82
Inventory	609.43	532.13	406.92	226.46	135.51	106.21
Other Current Assets	166.19	219.16	131.43	141.7	39.81	48.62
Total Current Assets	1,716	1,464	1,352	1,050	863.06	852.5
Property, Plant & Equipment	3,866	3,844	3,213	2,620	951.83	528.43
Long-Term Investments	119.29	124.45	123.45	112.4	40	7
Other Intangible Assets	145.69	150.04	137.73	86.28	73.17	43.98
Long-Term Deferred Tax Assets	123.39	145.3	86.54	49.39	40.48	14.39
Long-Term Deferred Charges	16.7	13.64	5.79	-	-	-
Other Long-Term Assets	58.8	33.51	71.17	51.9	58.54	27.8
Total Assets	6,045	5,775	4,989	3,970	2,027	1,474

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	502.57	712.68	564.03	589.01	221.64	99.87
Accrued Expenses	35.06	52.07	44	36.87	35.06	17.95
Short-Term Debt	249.25	123.38	681.98	915.12	79.23	18.5
Current Portion of Long-Term Debt	560.22	363.03	225.75	26.6	-	-
Current Income Taxes Payable	9.8	3.58	4.92	25.5	5.32	6.67
Current Unearned Revenue	27.14	17	17.4	12.77	19.61	17.57
Other Current Liabilities	127.76	67.59	65.45	70.61	27.9	22.34
Total Current Liabilities	1,512	1,339	1,604	1,676	388.75	182.89
Long-Term Debt	1,656	1,572	637.81	304.93	-	-
Long-Term Unearned Revenue	88.34	94.75	87.62	91.53	102.63	86.23
Long-Term Deferred Tax Liabilities	88.45	136.32	102.07	71.64	54.05	21.85
Total Liabilities	3,345	3,143	2,431	2,145	545.44	290.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	250.12	250.12	249.72	157.54	108.4	108.4
Additional Paid-In Capital	1,218	1,218	1,209	603.46	624.47	588.04
Retained Earnings	1,320	1,228	1,158	1,110	758.99	498.69
Treasury Stock	-50.01	-50.01	-53.61	-45.24	-12	-12
Comprehensive Income & Other	-1.57	0.43	0.96	0.72	0.64	-
Total Common Equity	2,736	2,647	2,565	1,827	1,480	1,183
Minority Interest	-35.45	-14.82	-6.27	-1.31	1.15	-
Shareholders' Equity	2,701	2,632	2,558	1,826	1,482	1,183
Total Liabilities & Equity	6,045	5,775	4,989	3,970	2,027	1,474

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,466	2,059	1,546	1,247	79.23	18.5
Net Cash (Debt)	-1,891	-1,775	-1,123	-893.67	268.55	444.35
Net Cash Growth	-	-	-	-	-39.56%	6128.38%
Net Cash Per Share	-7.63	-7.10	-4.86	-3.90	1.18	2.14
Filing Date Shares Outstanding	238.77	248.79	235.72	227.71	227.91	227.91
Total Common Shares Outstanding	238.77	248.79	235.72	227.71	227.91	227.91
Working Capital	204.15	124.76	-251.78	-626.43	474.3	669.61
Book Value Per Share	11.46	10.64	10.88	8.02	6.50	5.19
Tangible Book Value	2,590	2,497	2,427	1,741	1,407	1,139
Tangible Book Value Per Share	10.85	10.04	10.30	7.64	6.17	5.00
Buildings	-	862.98	755.99	462.42	290.67	200.66
Machinery	-	2,449	1,307	952.21	703.78	439.11
Construction In Progress	-	1,192	1,606	1,529	188.91	65.33

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error